FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2015489672> ?p ?o ?g. }

• W2015489672 endingPage "821" @default.
• W2015489672 startingPage "821" @default.
• W2015489672 abstract "Introduction: We wanted to identify the prognostic factors for overall survival (OS) in Chinese patients with metastatic renal cell carcinoma (mRCC) treated with first-line targeted therapy (sorafenib or sunitinib).Methods: We retrospectively reviewed clinical data from 119 mRCC patients administered sorafenib or sunitinib at the Ruijin Hospital since 2007. OS rates were calculated by the Kaplan-Meier method. Each variable was investigated univariately and then multivariately using a stepwise algorithm. A multivariate Cox regression model analyzed baseline variables for prognostic significance.Results: The mean patient age was 57 ± 12 years; 37 patients (31%) received sorafenib and 82 (69%) received sunitinib. The mean OS was 22.7 ± 15.6 months (range: 2.8–68.7). OS rates at year 1, 3 and 5 were 74%, 57%, and 36%, respectively. Univariate analysis identified significant negative prognostic factors (p < 0.05) as Eastern Cooperative Oncology Group (ECOG) performance status ≥2, symptoms, no prior nephrectomy, microscopic necrosis, ≥2 metastatic sites, presence of liver, bone, or pancreas metastasis, hemoglobin less than the lower limit of normal (female <115 g/L, male <130 g/L), and serum alkaline phosphatase greater than the upper limit of normal (126 IU/L) at baseline, as well as a relative dose intensity of targeting agents in the first month (1M-RDI) of <50%. Multivariate analysis of OS identified 4 independent predictors: no symptoms, no bone or pancreas metastasis, and 1M-RDI of targeting agents (≥50%).Conclusions: With targeted therapy, there is some change in the prognostic factors for mRCC and target drug therapies (1M-RDI ≥50%) play an important role in the prognosis of mRCC. Continued progress in the identification of patient-specific prognostic factors for mRCC will require further advances in the understanding of tumour biology." @default.
• W2015489672 created "2016-06-24" @default.
• W2015489672 creator A5013558185 @default.
• W2015489672 creator A5022585660 @default.
• W2015489672 creator A5023016256 @default.
• W2015489672 creator A5024120299 @default.
• W2015489672 creator A5048307621 @default.
• W2015489672 creator A5050787253 @default.
• W2015489672 creator A5056896393 @default.
• W2015489672 creator A5067759782 @default.
• W2015489672 creator A5075134210 @default.
• W2015489672 creator A5084410970 @default.
• W2015489672 date "2014-11-24" @default.
• W2015489672 modified "2023-10-16" @default.
• W2015489672 title "Prognostic factors for overall survival with targeted therapy in Chinese patients with metastatic renal cell carcinoma" @default.
• W2015489672 cites W1483649639 @default.
• W2015489672 cites W1889115263 @default.
• W2015489672 cites W1967836453 @default.
• W2015489672 cites W1968086675 @default.
• W2015489672 cites W1992142098 @default.
• W2015489672 cites W1992532818 @default.
• W2015489672 cites W1997550581 @default.
• W2015489672 cites W2003859804 @default.
• W2015489672 cites W2021256410 @default.
• W2015489672 cites W2022169059 @default.
• W2015489672 cites W2037837794 @default.
• W2015489672 cites W2069480574 @default.
• W2015489672 cites W2084778105 @default.
• W2015489672 cites W2099088585 @default.
• W2015489672 cites W2099752220 @default.
• W2015489672 cites W2102321740 @default.
• W2015489672 cites W2102900043 @default.
• W2015489672 cites W2106453307 @default.
• W2015489672 cites W2106568990 @default.
• W2015489672 cites W2109735642 @default.
• W2015489672 cites W2114180295 @default.
• W2015489672 cites W2116661424 @default.
• W2015489672 cites W2123784879 @default.
• W2015489672 cites W2137822543 @default.
• W2015489672 cites W2143782771 @default.
• W2015489672 cites W2147864956 @default.
• W2015489672 cites W2149407433 @default.
• W2015489672 cites W2149456801 @default.
• W2015489672 cites W2155196945 @default.
• W2015489672 doi "https://doi.org/10.5489/cuaj.2096" @default.
• W2015489672 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4250247" @default.
• W2015489672 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25485010" @default.
• W2015489672 hasPublicationYear "2014" @default.
• W2015489672 type Work @default.
• W2015489672 sameAs 2015489672 @default.
• W2015489672 citedByCount "8" @default.
• W2015489672 countsByYear W20154896722015 @default.
• W2015489672 countsByYear W20154896722016 @default.
• W2015489672 countsByYear W20154896722017 @default.
• W2015489672 crossrefType "journal-article" @default.
• W2015489672 hasAuthorship W2015489672A5013558185 @default.
• W2015489672 hasAuthorship W2015489672A5022585660 @default.
• W2015489672 hasAuthorship W2015489672A5023016256 @default.
• W2015489672 hasAuthorship W2015489672A5024120299 @default.
• W2015489672 hasAuthorship W2015489672A5048307621 @default.
• W2015489672 hasAuthorship W2015489672A5050787253 @default.
• W2015489672 hasAuthorship W2015489672A5056896393 @default.
• W2015489672 hasAuthorship W2015489672A5067759782 @default.
• W2015489672 hasAuthorship W2015489672A5075134210 @default.
• W2015489672 hasAuthorship W2015489672A5084410970 @default.
• W2015489672 hasBestOaLocation W20154896721 @default.
• W2015489672 hasConcept C121608353 @default.
• W2015489672 hasConcept C126322002 @default.
• W2015489672 hasConcept C126894567 @default.
• W2015489672 hasConcept C143998085 @default.
• W2015489672 hasConcept C144301174 @default.
• W2015489672 hasConcept C2777472916 @default.
• W2015489672 hasConcept C2777783956 @default.
• W2015489672 hasConcept C2778019345 @default.
• W2015489672 hasConcept C2778695046 @default.
• W2015489672 hasConcept C2779013556 @default.
• W2015489672 hasConcept C2779490328 @default.
• W2015489672 hasConcept C2781230642 @default.
• W2015489672 hasConcept C38180746 @default.
• W2015489672 hasConcept C50382708 @default.
• W2015489672 hasConcept C71924100 @default.
• W2015489672 hasConcept C90924648 @default.
• W2015489672 hasConceptScore W2015489672C121608353 @default.
• W2015489672 hasConceptScore W2015489672C126322002 @default.
• W2015489672 hasConceptScore W2015489672C126894567 @default.
• W2015489672 hasConceptScore W2015489672C143998085 @default.
• W2015489672 hasConceptScore W2015489672C144301174 @default.
• W2015489672 hasConceptScore W2015489672C2777472916 @default.
• W2015489672 hasConceptScore W2015489672C2777783956 @default.
• W2015489672 hasConceptScore W2015489672C2778019345 @default.
• W2015489672 hasConceptScore W2015489672C2778695046 @default.
• W2015489672 hasConceptScore W2015489672C2779013556 @default.
• W2015489672 hasConceptScore W2015489672C2779490328 @default.
• W2015489672 hasConceptScore W2015489672C2781230642 @default.
• W2015489672 hasConceptScore W2015489672C38180746 @default.
• W2015489672 hasConceptScore W2015489672C50382708 @default.
• W2015489672 hasConceptScore W2015489672C71924100 @default.
• W2015489672 hasConceptScore W2015489672C90924648 @default.

• next